News
Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This ...
22hon MSN
Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...
By having multiple epitopes in one molecule, MEFA vaccines can simultaneously target several features of the disease-causing ...
Cipla, a major pharmaceutical firm, is entering India's weight management market, focusing on obesity solutions. The company is also enhancing its CNS therapeutic offerings, having licensed Sanofi's ...
New Delhi: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang ...
Cipla expands into CNS and weight management segments, focusing on patient needs and innovation for long-term value.
Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...
The UN Environment Program (UNEP) has issued a stark warning that floods—becoming more frequent and intense due to climate change—are elevating the r ...
Welcome to our continuous live coverage bringing you the latest from across Africa. Stay informed with real-time updates, ...
The global population aged 65 and older is projected to increase from 10% in 2024 to 16% by 2050, primarily in low and middle ...
16h
The Brighterside of News on MSNBreakthrough mRNA vaccine shows 100% effectiveness against deadly bacteriaScientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine proven completely effective against deadly bacteria. This groundbreaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results